Cite

HARVARD Citation

    Zahir, H. et al. (2023). Pharmacokinetics of the Multi‐kinase Inhibitor Pexidartinib: Mass Balance and Dose Proportionality. Clinical pharmacology in drug development. 12 (2), pp. 159-167. [Online]. 
  
Back to record